This site is intended for UK healthcare professionals only
This webcast series and supporting materials was developed by the Chronic Conditions faculty in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the agenda, speaker selection, presentations or collateral content, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

Chronic Conditions Month 2025

Renal

Join us for a series of interactive webinars and podcasts to help you optimise care for people with chronic conditions

The agenda

13.00-13.45

Preventing chronic kidney disease (CKD) progression

  • CKD as a national health priority: Estimates of future demand for kidney replacement therapy
  • Management guidelines and new interventions to delay or prevent progression of CKD
  • Safe and effective initiation of treatments for CKD

13.45-14.20

Cardiorenal risk in type 2 diabetes: a case-based discussion

This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only

14.20-15.00

Managing comorbidities in people with kidney disease

  • Prevalence of cardiac or metabolic disease in people with kidney disease
  • Efficient and effective interventions for the management of cardiorenal metabolic disease
  • Streamlining multidisciplinary management across both primary and secondary care

AstraZeneca has provided sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence, except for the AstraZeneca sponsored symposium presentation.

The speakers

Andrew Frankel

Consultant Physician and Nephrologist Imperial College Healthcare NHS Trust

Andrew has been working as a consultant nephrologist at Imperial College Healthcare NHS trust since 1995. He has extensive experience in managing all aspects of kidney disease but has a particular interest in relation to the management of diabetes in the context of kidney disease. Andrew has Maintained a significant research interest in relation to diabetes and kidney, both in terms of how diabetes affects the kidneys leading to deterioration in kidney function, but also in relation to how the presence of kidney disease influences the management of diabetes.

He is published in relation to assessment of renal complications in people with diabetes and obesity. He has also played a significant role in the development of UK national guidelines on the management of diabetes in the context of kidney disease.

Andrew is joint editor of the UK Kidney Association guidelines on the use of SGLT2I in adults with chronic kidney disease. He is also an educational leader supporting the next generation of doctors, having been the director Imperial’s Foundation School from its inception to 2010, London lead for Foundation Training 2010 to 2013 and Postgraduate Dean for South London from 2013 and 2018.

 

Yassir Javaid

GPwSI Cardiology, Northampton

Dr Javaid qualified from Cambridge University and completed his VTS training in Northampton. He has a specialist interest in cardiology and echocardiography and was a clinical lead in the Northamptonshire Community Cardiology service, which had a focus on patients with heart failure and valve disease.

He was named Pulse “GP of the Year” in 2015 for his work in reducing stroke emergency admissions in the East Midlands. He is on the editorial board for the British Journal of Cardiology.

For healthcare professionals only

Are you a healthcare professional?

The information is intended for healthcare professionals only.
Please confirm below.